chr20-45891274-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The ENST00000372484(CTSA):c.-52G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000424 in 1,508,190 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00045 ( 1 hom. )
Consequence
CTSA
ENST00000372484 5_prime_UTR
ENST00000372484 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.269
Genes affected
CTSA (HGNC:9251): (cathepsin A) This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
NEURL2 (HGNC:16156): (neuralized E3 ubiquitin protein ligase 2) This gene encodes a protein that is involved in the regulation of myofibril organization. This protein is likely the adaptor component of the E3 ubiquitin ligase complex in striated muscle, and it regulates the ubiquitin-mediated degradation of beta-catenin during myogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000454 (615/1355828) while in subpopulation NFE AF = 0.00058 (603/1040238). AF 95% confidence interval is 0.000541. There are 1 homozygotes in GnomAdExome4. There are 282 alleles in the male GnomAdExome4 subpopulation. Median coverage is 25. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152244Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25
AN:
152244
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000454 AC: 615AN: 1355828Hom.: 1 Cov.: 25 AF XY: 0.000420 AC XY: 282AN XY: 671192 show subpopulations
GnomAD4 exome
AF:
AC:
615
AN:
1355828
Hom.:
Cov.:
25
AF XY:
AC XY:
282
AN XY:
671192
Gnomad4 AFR exome
AF:
AC:
1
AN:
30754
Gnomad4 AMR exome
AF:
AC:
0
AN:
35662
Gnomad4 ASJ exome
AF:
AC:
0
AN:
24934
Gnomad4 EAS exome
AF:
AC:
0
AN:
35580
Gnomad4 SAS exome
AF:
AC:
0
AN:
78280
Gnomad4 FIN exome
AF:
AC:
0
AN:
48252
Gnomad4 NFE exome
AF:
AC:
603
AN:
1040238
Gnomad4 Remaining exome
AF:
AC:
11
AN:
56620
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000164 AC: 25AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74508 show subpopulations
GnomAD4 genome
AF:
AC:
25
AN:
152362
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74508
Gnomad4 AFR
AF:
AC:
0.0000961723
AN:
0.0000961723
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000308696
AN:
0.000308696
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Combined deficiency of sialidase AND beta galactosidase Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at